nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetohydroxamic Acid—Hydroxyurea—hematologic cancer	0.86	1	CrCtD
Acetohydroxamic Acid—Pyruvic acid—PC—hematologic cancer	0.00285	1	CrCbGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—TNFSF13B—hematologic cancer	0.00212	0.0767	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—TGFBR3—hematologic cancer	0.00173	0.0625	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—CMA1—hematologic cancer	0.000982	0.0356	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—HGF—hematologic cancer	0.000884	0.032	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PDGFRB—hematologic cancer	0.00086	0.0312	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—ITGAD—hematologic cancer	0.000792	0.0287	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—SERPINH1—hematologic cancer	0.000751	0.0272	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—SUMO1—hematologic cancer	0.000716	0.0259	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—FN1—hematologic cancer	0.000686	0.0249	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—JUND—hematologic cancer	0.000674	0.0244	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—FOXP3—hematologic cancer	0.000661	0.0239	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—CD44—hematologic cancer	0.000633	0.0229	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—ITGAE—hematologic cancer	0.0006	0.0217	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—NUP214—hematologic cancer	0.000596	0.0216	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—PML—hematologic cancer	0.000569	0.0206	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—AGRN—hematologic cancer	0.00051	0.0185	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—ITGAX—hematologic cancer	0.000462	0.0167	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Matrix Metalloproteinases—TNF—hematologic cancer	0.000441	0.016	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—CMA1—hematologic cancer	0.000411	0.0149	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SRC—hematologic cancer	0.000403	0.0146	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—GRB2—hematologic cancer	0.000392	0.0142	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—ITGAL—hematologic cancer	0.00038	0.0138	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—IL4—hematologic cancer	0.000376	0.0136	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CDKN2B—hematologic cancer	0.000373	0.0135	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—hematologic cancer	0.00036	0.0131	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—NCAM1—hematologic cancer	0.000335	0.0121	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CDK2—hematologic cancer	0.000323	0.0117	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—TERT—hematologic cancer	0.000312	0.0113	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—SDC1—hematologic cancer	0.000312	0.0113	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—SPARC—hematologic cancer	0.000312	0.0113	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CDK4—hematologic cancer	0.000305	0.0111	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—ICAM1—hematologic cancer	0.000299	0.0108	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MAPK14—hematologic cancer	0.000283	0.0103	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MET—hematologic cancer	0.000279	0.0101	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—FN1—hematologic cancer	0.000275	0.00994	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—FOS—hematologic cancer	0.000274	0.00992	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CCL2—hematologic cancer	0.000268	0.00969	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—RB1—hematologic cancer	0.000265	0.00962	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—ITGA4—hematologic cancer	0.000265	0.0096	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—CD44—hematologic cancer	0.000265	0.0096	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—CASP3—hematologic cancer	0.000254	0.00919	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—FOS—hematologic cancer	0.00025	0.00907	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CREBBP—hematologic cancer	0.000244	0.00882	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MAP2K1—hematologic cancer	0.000232	0.00842	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—IFNG—hematologic cancer	0.000228	0.00824	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—PDGFA—hematologic cancer	0.000224	0.00813	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—PIK3R1—hematologic cancer	0.000218	0.0079	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CDKN1B—hematologic cancer	0.000207	0.00749	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—IL1B—hematologic cancer	0.000203	0.00735	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CASP3—hematologic cancer	0.000203	0.00734	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—IL2—hematologic cancer	0.000202	0.00733	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CCND1—hematologic cancer	0.000197	0.00714	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CCND1—hematologic cancer	0.00018	0.00653	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—JUN—hematologic cancer	0.00018	0.00651	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—PDGFB—hematologic cancer	0.000175	0.00633	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CDKN1A—hematologic cancer	0.000174	0.00632	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MAPK8—hematologic cancer	0.00017	0.00616	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—EP300—hematologic cancer	0.000166	0.00601	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—MAPK3—hematologic cancer	0.000163	0.00589	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—SRC—hematologic cancer	0.000161	0.00584	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—MYC—hematologic cancer	0.000158	0.00573	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—TGFB1—hematologic cancer	0.000158	0.00571	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—FN1—hematologic cancer	0.000158	0.00571	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—ICAM1—hematologic cancer	0.000157	0.00569	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—TNF—hematologic cancer	0.000147	0.00534	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MYC—hematologic cancer	0.000145	0.00524	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—TGFB1—hematologic cancer	0.000144	0.00522	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—TP53—hematologic cancer	0.00013	0.0047	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—FGF2—hematologic cancer	0.000127	0.0046	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—IL6—hematologic cancer	0.000119	0.00431	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—TP53—hematologic cancer	0.000119	0.0043	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—CASP3—hematologic cancer	0.000106	0.00385	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—AKT1—hematologic cancer	0.0001	0.00363	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—TGFB1—hematologic cancer	8.28e-05	0.003	CbGpPWpGaD
Acetohydroxamic Acid—Lethargy—Doxorubicin—hematologic cancer	7.2e-05	0.000656	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Vincristine—hematologic cancer	7.18e-05	0.000654	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Bortezomib—hematologic cancer	7.16e-05	0.000652	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Vincristine—hematologic cancer	7.13e-05	0.000649	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Carmustine—hematologic cancer	7.13e-05	0.000649	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Vincristine—hematologic cancer	7.12e-05	0.000648	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Bleomycin—hematologic cancer	7.11e-05	0.000647	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Melphalan—hematologic cancer	7.1e-05	0.000646	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Alitretinoin—hematologic cancer	7.06e-05	0.000643	CcSEcCtD
Acetohydroxamic Acid—Rash—Melphalan—hematologic cancer	7.04e-05	0.000641	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Melphalan—hematologic cancer	7.03e-05	0.00064	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Vinorelbine—hematologic cancer	7e-05	0.000637	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Irinotecan—hematologic cancer	6.99e-05	0.000637	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Mitoxantrone—hematologic cancer	6.99e-05	0.000637	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Ifosfamide—hematologic cancer	6.98e-05	0.000636	CcSEcCtD
Acetohydroxamic Acid—Nausea—Vinblastine—hematologic cancer	6.97e-05	0.000635	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Cisplatin—hematologic cancer	6.96e-05	0.000634	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Irinotecan—hematologic cancer	6.94e-05	0.000632	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Irinotecan—hematologic cancer	6.93e-05	0.000631	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Mitoxantrone—hematologic cancer	6.93e-05	0.000631	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Lenalidomide—hematologic cancer	6.9e-05	0.000628	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Triamcinolone—hematologic cancer	6.9e-05	0.000628	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Etoposide—hematologic cancer	6.89e-05	0.000628	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Betamethasone—hematologic cancer	6.85e-05	0.000624	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Dexamethasone—hematologic cancer	6.85e-05	0.000624	CcSEcCtD
Acetohydroxamic Acid—Rash—Lenalidomide—hematologic cancer	6.84e-05	0.000623	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Lenalidomide—hematologic cancer	6.84e-05	0.000623	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Gemcitabine—hematologic cancer	6.81e-05	0.00062	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Hydroxyurea—hematologic cancer	6.8e-05	0.00062	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Prednisolone—hematologic cancer	6.8e-05	0.000619	CcSEcCtD
Acetohydroxamic Acid—Headache—Lenalidomide—hematologic cancer	6.8e-05	0.000619	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Gemcitabine—hematologic cancer	6.76e-05	0.000616	CcSEcCtD
Acetohydroxamic Acid—Abdominal discomfort—Methotrexate—hematologic cancer	6.75e-05	0.000615	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Gemcitabine—hematologic cancer	6.75e-05	0.000615	CcSEcCtD
Acetohydroxamic Acid—Rash—Hydroxyurea—hematologic cancer	6.75e-05	0.000614	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Hydroxyurea—hematologic cancer	6.74e-05	0.000614	CcSEcCtD
Acetohydroxamic Acid—Malaise—Triamcinolone—hematologic cancer	6.7e-05	0.00061	CcSEcCtD
Acetohydroxamic Acid—Headache—Hydroxyurea—hematologic cancer	6.7e-05	0.00061	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Thiotepa—hematologic cancer	6.68e-05	0.000608	CcSEcCtD
Acetohydroxamic Acid—Nausea—Melphalan—hematologic cancer	6.63e-05	0.000604	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Irinotecan—hematologic cancer	6.63e-05	0.000603	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Mitoxantrone—hematologic cancer	6.63e-05	0.000603	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Thalidomide—hematologic cancer	6.46e-05	0.000588	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Gemcitabine—hematologic cancer	6.46e-05	0.000588	CcSEcCtD
Acetohydroxamic Acid—Nausea—Lenalidomide—hematologic cancer	6.45e-05	0.000587	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Etoposide—hematologic cancer	6.38e-05	0.000581	CcSEcCtD
Acetohydroxamic Acid—Nausea—Hydroxyurea—hematologic cancer	6.36e-05	0.000579	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Bortezomib—hematologic cancer	6.35e-05	0.000578	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Cisplatin—hematologic cancer	6.35e-05	0.000578	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Cisplatin—hematologic cancer	6.3e-05	0.000574	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Bleomycin—hematologic cancer	6.3e-05	0.000574	CcSEcCtD
Acetohydroxamic Acid—Rash—Bortezomib—hematologic cancer	6.3e-05	0.000573	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Bortezomib—hematologic cancer	6.29e-05	0.000573	CcSEcCtD
Acetohydroxamic Acid—Depression—Methotrexate—hematologic cancer	6.26e-05	0.00057	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Betamethasone—hematologic cancer	6.26e-05	0.00057	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Dexamethasone—hematologic cancer	6.26e-05	0.00057	CcSEcCtD
Acetohydroxamic Acid—Headache—Bortezomib—hematologic cancer	6.26e-05	0.00057	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Triamcinolone—hematologic cancer	6.25e-05	0.000569	CcSEcCtD
Acetohydroxamic Acid—Rash—Bleomycin—hematologic cancer	6.25e-05	0.000569	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Bleomycin—hematologic cancer	6.24e-05	0.000568	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Carmustine—hematologic cancer	6.21e-05	0.000565	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Vinorelbine—hematologic cancer	6.2e-05	0.000565	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Methotrexate—hematologic cancer	6.18e-05	0.000562	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Alitretinoin—hematologic cancer	6.15e-05	0.00056	CcSEcCtD
Acetohydroxamic Acid—Rash—Vinorelbine—hematologic cancer	6.15e-05	0.00056	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Vinorelbine—hematologic cancer	6.14e-05	0.000559	CcSEcCtD
Acetohydroxamic Acid—Headache—Vinorelbine—hematologic cancer	6.11e-05	0.000556	CcSEcCtD
Acetohydroxamic Acid—Malaise—Betamethasone—hematologic cancer	6.08e-05	0.000554	CcSEcCtD
Acetohydroxamic Acid—Malaise—Dexamethasone—hematologic cancer	6.08e-05	0.000554	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Ifosfamide—hematologic cancer	6.08e-05	0.000553	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Cisplatin—hematologic cancer	6.02e-05	0.000548	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Prednisone—hematologic cancer	5.96e-05	0.000543	CcSEcCtD
Acetohydroxamic Acid—Nausea—Bortezomib—hematologic cancer	5.93e-05	0.00054	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Vincristine—hematologic cancer	5.92e-05	0.00054	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Thiotepa—hematologic cancer	5.92e-05	0.000539	CcSEcCtD
Acetohydroxamic Acid—Nausea—Bleomycin—hematologic cancer	5.89e-05	0.000536	CcSEcCtD
Acetohydroxamic Acid—Rash—Thiotepa—hematologic cancer	5.87e-05	0.000535	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Thiotepa—hematologic cancer	5.87e-05	0.000534	CcSEcCtD
Acetohydroxamic Acid—Headache—Thiotepa—hematologic cancer	5.83e-05	0.000531	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Etoposide—hematologic cancer	5.81e-05	0.00053	CcSEcCtD
Acetohydroxamic Acid—Nausea—Vinorelbine—hematologic cancer	5.79e-05	0.000527	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Epirubicin—hematologic cancer	5.78e-05	0.000526	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Etoposide—hematologic cancer	5.77e-05	0.000526	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Mitoxantrone—hematologic cancer	5.77e-05	0.000525	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Irinotecan—hematologic cancer	5.77e-05	0.000525	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Etoposide—hematologic cancer	5.77e-05	0.000525	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Thalidomide—hematologic cancer	5.73e-05	0.000521	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Dexamethasone—hematologic cancer	5.72e-05	0.000521	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Betamethasone—hematologic cancer	5.72e-05	0.000521	CcSEcCtD
Acetohydroxamic Acid—Rash—Thalidomide—hematologic cancer	5.68e-05	0.000517	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Dexamethasone—hematologic cancer	5.67e-05	0.000517	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Betamethasone—hematologic cancer	5.67e-05	0.000517	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Thalidomide—hematologic cancer	5.67e-05	0.000517	CcSEcCtD
Acetohydroxamic Acid—Headache—Thalidomide—hematologic cancer	5.64e-05	0.000514	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Gemcitabine—hematologic cancer	5.62e-05	0.000512	CcSEcCtD
Acetohydroxamic Acid—Nausea—Thiotepa—hematologic cancer	5.53e-05	0.000504	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Etoposide—hematologic cancer	5.51e-05	0.000502	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Carmustine—hematologic cancer	5.5e-05	0.000501	CcSEcCtD
Acetohydroxamic Acid—Rash—Carmustine—hematologic cancer	5.45e-05	0.000497	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Prednisone—hematologic cancer	5.45e-05	0.000496	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Carmustine—hematologic cancer	5.45e-05	0.000496	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Alitretinoin—hematologic cancer	5.45e-05	0.000496	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Prednisolone—hematologic cancer	5.44e-05	0.000495	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Prednisone—hematologic cancer	5.43e-05	0.000494	CcSEcCtD
Acetohydroxamic Acid—Headache—Carmustine—hematologic cancer	5.42e-05	0.000493	CcSEcCtD
Acetohydroxamic Acid—Rash—Alitretinoin—hematologic cancer	5.4e-05	0.000492	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Alitretinoin—hematologic cancer	5.4e-05	0.000492	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Ifosfamide—hematologic cancer	5.38e-05	0.00049	CcSEcCtD
Acetohydroxamic Acid—Headache—Alitretinoin—hematologic cancer	5.37e-05	0.000489	CcSEcCtD
Acetohydroxamic Acid—Nausea—Thalidomide—hematologic cancer	5.35e-05	0.000487	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Doxorubicin—hematologic cancer	5.35e-05	0.000487	CcSEcCtD
Acetohydroxamic Acid—Rash—Ifosfamide—hematologic cancer	5.34e-05	0.000486	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Ifosfamide—hematologic cancer	5.33e-05	0.000486	CcSEcCtD
Acetohydroxamic Acid—Malaise—Prednisone—hematologic cancer	5.3e-05	0.000482	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Vincristine—hematologic cancer	5.25e-05	0.000478	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Dexamethasone—hematologic cancer	5.25e-05	0.000478	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Betamethasone—hematologic cancer	5.25e-05	0.000478	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Cisplatin—hematologic cancer	5.24e-05	0.000477	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Triamcinolone—hematologic cancer	5.23e-05	0.000476	CcSEcCtD
Acetohydroxamic Acid—Rash—Vincristine—hematologic cancer	5.21e-05	0.000474	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Vincristine—hematologic cancer	5.2e-05	0.000474	CcSEcCtD
Acetohydroxamic Acid—Headache—Vincristine—hematologic cancer	5.17e-05	0.000471	CcSEcCtD
Acetohydroxamic Acid—Nausea—Carmustine—hematologic cancer	5.14e-05	0.000468	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Mitoxantrone—hematologic cancer	5.11e-05	0.000466	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Irinotecan—hematologic cancer	5.11e-05	0.000466	CcSEcCtD
Acetohydroxamic Acid—Nausea—Alitretinoin—hematologic cancer	5.09e-05	0.000464	CcSEcCtD
Acetohydroxamic Acid—Rash—Mitoxantrone—hematologic cancer	5.07e-05	0.000462	CcSEcCtD
Acetohydroxamic Acid—Rash—Irinotecan—hematologic cancer	5.07e-05	0.000462	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Irinotecan—hematologic cancer	5.07e-05	0.000461	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Mitoxantrone—hematologic cancer	5.07e-05	0.000461	CcSEcCtD
Acetohydroxamic Acid—Headache—Mitoxantrone—hematologic cancer	5.04e-05	0.000459	CcSEcCtD
Acetohydroxamic Acid—Headache—Irinotecan—hematologic cancer	5.04e-05	0.000459	CcSEcCtD
Acetohydroxamic Acid—Nausea—Ifosfamide—hematologic cancer	5.03e-05	0.000458	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Triamcinolone—hematologic cancer	5e-05	0.000455	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Prednisone—hematologic cancer	4.98e-05	0.000454	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Methotrexate—hematologic cancer	4.98e-05	0.000454	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Gemcitabine—hematologic cancer	4.98e-05	0.000454	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Prednisone—hematologic cancer	4.94e-05	0.00045	CcSEcCtD
Acetohydroxamic Acid—Rash—Gemcitabine—hematologic cancer	4.94e-05	0.00045	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Gemcitabine—hematologic cancer	4.93e-05	0.000449	CcSEcCtD
Acetohydroxamic Acid—Headache—Gemcitabine—hematologic cancer	4.91e-05	0.000447	CcSEcCtD
Acetohydroxamic Acid—Nausea—Vincristine—hematologic cancer	4.9e-05	0.000447	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Etoposide—hematologic cancer	4.8e-05	0.000437	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Dexamethasone—hematologic cancer	4.79e-05	0.000436	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Betamethasone—hematologic cancer	4.79e-05	0.000436	CcSEcCtD
Acetohydroxamic Acid—Nausea—Mitoxantrone—hematologic cancer	4.78e-05	0.000435	CcSEcCtD
Acetohydroxamic Acid—Nausea—Irinotecan—hematologic cancer	4.78e-05	0.000435	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.75e-05	0.000433	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.75e-05	0.000433	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Betamethasone—hematologic cancer	4.75e-05	0.000432	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Dexamethasone—hematologic cancer	4.75e-05	0.000432	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Epirubicin—hematologic cancer	4.66e-05	0.000425	CcSEcCtD
Acetohydroxamic Acid—Nausea—Gemcitabine—hematologic cancer	4.65e-05	0.000424	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Cisplatin—hematologic cancer	4.64e-05	0.000423	CcSEcCtD
Acetohydroxamic Acid—Rash—Cisplatin—hematologic cancer	4.6e-05	0.000419	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Cisplatin—hematologic cancer	4.6e-05	0.000419	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Prednisone—hematologic cancer	4.57e-05	0.000416	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Methotrexate—hematologic cancer	4.55e-05	0.000415	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Methotrexate—hematologic cancer	4.54e-05	0.000413	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Dexamethasone—hematologic cancer	4.54e-05	0.000413	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Betamethasone—hematologic cancer	4.54e-05	0.000413	CcSEcCtD
Acetohydroxamic Acid—Tension—Epirubicin—hematologic cancer	4.51e-05	0.000411	CcSEcCtD
Acetohydroxamic Acid—Nervousness—Epirubicin—hematologic cancer	4.46e-05	0.000406	CcSEcCtD
Acetohydroxamic Acid—Malaise—Methotrexate—hematologic cancer	4.43e-05	0.000403	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Triamcinolone—hematologic cancer	4.35e-05	0.000396	CcSEcCtD
Acetohydroxamic Acid—Nausea—Cisplatin—hematologic cancer	4.34e-05	0.000395	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Doxorubicin—hematologic cancer	4.32e-05	0.000393	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Epirubicin—hematologic cancer	4.26e-05	0.000388	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Etoposide—hematologic cancer	4.25e-05	0.000387	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Epirubicin—hematologic cancer	4.25e-05	0.000387	CcSEcCtD
Acetohydroxamic Acid—Rash—Etoposide—hematologic cancer	4.22e-05	0.000384	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Etoposide—hematologic cancer	4.21e-05	0.000384	CcSEcCtD
Acetohydroxamic Acid—Headache—Etoposide—hematologic cancer	4.19e-05	0.000382	CcSEcCtD
Acetohydroxamic Acid—Tension—Doxorubicin—hematologic cancer	4.17e-05	0.00038	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Prednisone—hematologic cancer	4.17e-05	0.00038	CcSEcCtD
Acetohydroxamic Acid—Rash—Prednisolone—hematologic cancer	4.16e-05	0.000379	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Prednisolone—hematologic cancer	4.16e-05	0.000378	CcSEcCtD
Acetohydroxamic Acid—Malaise—Epirubicin—hematologic cancer	4.14e-05	0.000377	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Prednisone—hematologic cancer	4.13e-05	0.000376	CcSEcCtD
Acetohydroxamic Acid—Headache—Prednisolone—hematologic cancer	4.13e-05	0.000376	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Methotrexate—hematologic cancer	4.13e-05	0.000376	CcSEcCtD
Acetohydroxamic Acid—Nervousness—Doxorubicin—hematologic cancer	4.13e-05	0.000376	CcSEcCtD
Acetohydroxamic Acid—Palpitations—Epirubicin—hematologic cancer	4.06e-05	0.00037	CcSEcCtD
Acetohydroxamic Acid—Nausea—Etoposide—hematologic cancer	3.97e-05	0.000362	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Prednisone—hematologic cancer	3.95e-05	0.00036	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Dexamethasone—hematologic cancer	3.95e-05	0.00036	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Betamethasone—hematologic cancer	3.95e-05	0.00036	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Doxorubicin—hematologic cancer	3.94e-05	0.000359	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Doxorubicin—hematologic cancer	3.93e-05	0.000358	CcSEcCtD
Acetohydroxamic Acid—Nausea—Prednisolone—hematologic cancer	3.92e-05	0.000357	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Epirubicin—hematologic cancer	3.9e-05	0.000355	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Epirubicin—hematologic cancer	3.86e-05	0.000352	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Triamcinolone—hematologic cancer	3.86e-05	0.000351	CcSEcCtD
Acetohydroxamic Acid—Malaise—Doxorubicin—hematologic cancer	3.83e-05	0.000349	CcSEcCtD
Acetohydroxamic Acid—Rash—Triamcinolone—hematologic cancer	3.83e-05	0.000348	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Triamcinolone—hematologic cancer	3.82e-05	0.000348	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Methotrexate—hematologic cancer	3.82e-05	0.000348	CcSEcCtD
Acetohydroxamic Acid—Headache—Triamcinolone—hematologic cancer	3.8e-05	0.000346	CcSEcCtD
Acetohydroxamic Acid—Palpitations—Doxorubicin—hematologic cancer	3.76e-05	0.000342	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Doxorubicin—hematologic cancer	3.61e-05	0.000328	CcSEcCtD
Acetohydroxamic Acid—Nausea—Triamcinolone—hematologic cancer	3.6e-05	0.000328	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Doxorubicin—hematologic cancer	3.58e-05	0.000326	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Epirubicin—hematologic cancer	3.57e-05	0.000325	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Dexamethasone—hematologic cancer	3.5e-05	0.000319	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Betamethasone—hematologic cancer	3.5e-05	0.000319	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Methotrexate—hematologic cancer	3.48e-05	0.000317	CcSEcCtD
Acetohydroxamic Acid—Rash—Dexamethasone—hematologic cancer	3.47e-05	0.000316	CcSEcCtD
Acetohydroxamic Acid—Rash—Betamethasone—hematologic cancer	3.47e-05	0.000316	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Betamethasone—hematologic cancer	3.47e-05	0.000316	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Dexamethasone—hematologic cancer	3.47e-05	0.000316	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.46e-05	0.000315	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Methotrexate—hematologic cancer	3.45e-05	0.000315	CcSEcCtD
Acetohydroxamic Acid—Headache—Betamethasone—hematologic cancer	3.45e-05	0.000314	CcSEcCtD
Acetohydroxamic Acid—Headache—Dexamethasone—hematologic cancer	3.45e-05	0.000314	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Prednisone—hematologic cancer	3.44e-05	0.000313	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Doxorubicin—hematologic cancer	3.31e-05	0.000301	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Methotrexate—hematologic cancer	3.3e-05	0.000301	CcSEcCtD
Acetohydroxamic Acid—Nausea—Dexamethasone—hematologic cancer	3.27e-05	0.000298	CcSEcCtD
Acetohydroxamic Acid—Nausea—Betamethasone—hematologic cancer	3.27e-05	0.000298	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Epirubicin—hematologic cancer	3.26e-05	0.000297	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.24e-05	0.000295	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Epirubicin—hematologic cancer	3.23e-05	0.000294	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Epirubicin—hematologic cancer	3.09e-05	0.000281	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Prednisone—hematologic cancer	3.05e-05	0.000278	CcSEcCtD
Acetohydroxamic Acid—Rash—Prednisone—hematologic cancer	3.02e-05	0.000275	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Prednisone—hematologic cancer	3.02e-05	0.000275	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Doxorubicin—hematologic cancer	3.02e-05	0.000275	CcSEcCtD
Acetohydroxamic Acid—Headache—Prednisone—hematologic cancer	3e-05	0.000274	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3e-05	0.000273	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Doxorubicin—hematologic cancer	2.99e-05	0.000272	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Methotrexate—hematologic cancer	2.87e-05	0.000262	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Doxorubicin—hematologic cancer	2.86e-05	0.00026	CcSEcCtD
Acetohydroxamic Acid—Nausea—Prednisone—hematologic cancer	2.85e-05	0.000259	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Epirubicin—hematologic cancer	2.69e-05	0.000245	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Methotrexate—hematologic cancer	2.55e-05	0.000232	CcSEcCtD
Acetohydroxamic Acid—Rash—Methotrexate—hematologic cancer	2.53e-05	0.00023	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Methotrexate—hematologic cancer	2.52e-05	0.00023	CcSEcCtD
Acetohydroxamic Acid—Headache—Methotrexate—hematologic cancer	2.51e-05	0.000229	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Doxorubicin—hematologic cancer	2.49e-05	0.000227	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Epirubicin—hematologic cancer	2.38e-05	0.000217	CcSEcCtD
Acetohydroxamic Acid—Nausea—Methotrexate—hematologic cancer	2.38e-05	0.000217	CcSEcCtD
Acetohydroxamic Acid—Rash—Epirubicin—hematologic cancer	2.36e-05	0.000215	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Epirubicin—hematologic cancer	2.36e-05	0.000215	CcSEcCtD
Acetohydroxamic Acid—Headache—Epirubicin—hematologic cancer	2.35e-05	0.000214	CcSEcCtD
Acetohydroxamic Acid—Nausea—Epirubicin—hematologic cancer	2.23e-05	0.000203	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Doxorubicin—hematologic cancer	2.21e-05	0.000201	CcSEcCtD
Acetohydroxamic Acid—Rash—Doxorubicin—hematologic cancer	2.19e-05	0.000199	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Doxorubicin—hematologic cancer	2.19e-05	0.000199	CcSEcCtD
Acetohydroxamic Acid—Headache—Doxorubicin—hematologic cancer	2.17e-05	0.000198	CcSEcCtD
Acetohydroxamic Acid—Nausea—Doxorubicin—hematologic cancer	2.06e-05	0.000188	CcSEcCtD
